Clinical Trial Update: Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating prophylactic antipyretic treatment in children receiving pneumococcal conjugate and standard infant vaccines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Not specified

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED